Yanan Bu

834 total citations
15 papers, 628 citations indexed

About

Yanan Bu is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Yanan Bu has authored 15 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Epidemiology and 5 papers in Cancer Research. Recurrent topics in Yanan Bu's work include Hepatitis B Virus Studies (10 papers), RNA modifications and cancer (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Yanan Bu is often cited by papers focused on Hepatitis B Virus Studies (10 papers), RNA modifications and cancer (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Yanan Bu collaborates with scholars based in China. Yanan Bu's co-authors include Man Zhao, Xiaodong Zhang, Guang Yang, Jinyan Feng, Hongfeng Yuan, Yunxia Liu, Haolin Yun, Ying Yuan, Shuqin Zhang and Mingming Sun and has published in prestigious journals such as Hepatology, Biochemical and Biophysical Research Communications and PLoS Pathogens.

In The Last Decade

Yanan Bu

15 papers receiving 625 citations

Peers

Yanan Bu
Haolin Yun China
Yongming Fu China
Yoon Ik Lee South Korea
Dae-Ghon Kim South Korea
Giulia Refolo Italy
Di Qu China
Bingyu Ye China
Pablo Ríos‐Marco Spain
Guang Song China
Haolin Yun China
Yanan Bu
Citations per year, relative to Yanan Bu Yanan Bu (= 1×) peers Haolin Yun

Countries citing papers authored by Yanan Bu

Since Specialization
Citations

This map shows the geographic impact of Yanan Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanan Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanan Bu more than expected).

Fields of papers citing papers by Yanan Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanan Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanan Bu. The network helps show where Yanan Bu may publish in the future.

Co-authorship network of co-authors of Yanan Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanan Bu. A scholar is included among the top collaborators of Yanan Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanan Bu. Yanan Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zhao, Man, Hongfeng Yuan, Yufei Wang, et al.. (2024). Tumour cell-expressed PD-L1 reprograms lipid metabolism via EGFR/ITGB4/SREBP1c signalling in liver cancer. JHEP Reports. 6(4). 101009–101009. 11 indexed citations
2.
Zheng, Yingcheng, Mengfei Wang, Yanan Bu, et al.. (2024). Hepatitis B virus RNAs co-opt ELAVL1 for stabilization and CRM1-dependent nuclear export. PLoS Pathogens. 20(2). e1011999–e1011999. 7 indexed citations
3.
Bu, Yanan, Kaitao Zhao, Yingcheng Zheng, et al.. (2023). Antibiotic-induced gut bacteria depletion has no effect on HBV replication in HBV immune tolerance mouse model. Virologica Sinica. 38(3). 335–343. 5 indexed citations
4.
Zheng, Yingcheng, Mengfei Wang, Sitong Li, et al.. (2023). Hepatitis B virus hijacks TSG101 to facilitate egress via multiple vesicle bodies. PLoS Pathogens. 19(5). e1011382–e1011382. 21 indexed citations
5.
Liu, Zixian, Jiapei Wang, Hongfeng Yuan, et al.. (2020). IFN-α2b inhibits the ethanol enriched-HBV cccDNA through blocking a positive feedback loop of HBx/MSL2/cccDNA/HBV/HBx in liver. Biochemical and Biophysical Research Communications. 527(1). 76–82. 6 indexed citations
6.
Liu, Zixian, Jiapei Wang, Lei Liu, et al.. (2020). Chronic ethanol consumption and HBV induce abnormal lipid metabolism through HBx/SWELL1/arachidonic acid signaling and activate Tregs in HBV-Tg mice. Theranostics. 10(20). 9249–9267. 26 indexed citations
7.
Yang, Guang, Ying Yuan, Hongfeng Yuan, et al.. (2020). Histone acetyltransferase 1 is a succinyltransferase for histones and non‐histones and promotes tumorigenesis. EMBO Reports. 22(2). e50967–e50967. 113 indexed citations
8.
Feng, Jinyan, Guang Yang, Yunxia Liu, et al.. (2019). LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer. Theranostics. 9(18). 5227–5245. 128 indexed citations
9.
Yang, Guang, Jinyan Feng, Yunxia Liu, et al.. (2019). HAT1 signaling confers to assembly and epigenetic regulation of HBV cccDNA minichromosome. Theranostics. 9(24). 7345–7358. 54 indexed citations
10.
Zhao, Man, Yanan Bu, Jinyan Feng, et al.. (2019). SPIN1 triggers abnormal lipid metabolism and enhances tumor growth in liver cancer. Cancer Letters. 470. 54–63. 51 indexed citations
11.
Liu, Yunxia, Jinyan Feng, Mingming Sun, et al.. (2019). Long non-coding RNA HULC activates HBV by modulating HBx/STAT3/miR-539/APOBEC3B signaling in HBV-related hepatocellular carcinoma. Cancer Letters. 454. 158–170. 69 indexed citations
12.
Liu, Yunxia, Jinyan Feng, Mingming Sun, et al.. (2018). Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism. Acta Pharmacologica Sinica. 40(1). 122–132. 47 indexed citations
13.
Zhang, Shuqin, Shan Gao, Man Zhao, et al.. (2017). Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein. Cancer Letters. 392. 94–104. 23 indexed citations
14.
15.
Bu, Yanan & Jian Yu. (2015). [Rosiglitazone protects against endotoxin-induced acute liver injury in rats].. PubMed. 95(39). 3180–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haolin Yun Breakdown of academic impact, for papers by Yongming Fu Breakdown of academic impact, for papers by Yoon Ik Lee Breakdown of academic impact, for papers by Dae-Ghon Kim Breakdown of academic impact, for papers by Giulia Refolo Breakdown of academic impact, for papers by Di Qu Breakdown of academic impact, for papers by Bingyu Ye Breakdown of academic impact, for papers by Pablo Ríos‐Marco Breakdown of academic impact, for papers by Guang Song
Rankless by CCL
2026